PubMed

Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.

Petrik JJ, Gerstein HC, Cesta CE, Kellenberger LD, Alfaidy N, Holloway AC.

Endocrine. 2009 Oct;36(2):281-90. Epub 2009 Aug 20.PMID: 19693712 [PubMed - in process]Related articles

Albuminuria in chronic heart failure: prevalence and prognostic importance.

Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees.

Lancet. 2009 Aug 15;374(9689):543-50.PMID: 19683640 [PubMed - indexed for MEDLINE]Related articles

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M.

Diabetologia. 2009 Nov;52(11):2288-98. Epub 2009 Aug 5.PMID: 19655124 [PubMed - in process]Related articles

Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.

Hanley AJ, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B.

J Clin Endocrinol Metab. 2009 Oct;94(10):3824-32. Epub 2009 Jul 21.PMID: 19622625 [PubMed - indexed for MEDLINE]Related articles

Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators.

J Am Coll Cardiol. 2009 Jun 2;53(22):2028-35.PMID: 19477351 [PubMed - indexed for MEDLINE]Related articles

Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Gerstein HC.

Nat Rev Endocrinol. 2009 May;5(5):270-5. Review.PMID: 19444260 [PubMed - indexed for MEDLINE]Related articles

Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.

Goyal A, Mehta SR, Gerstein HC, Díaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi KA, Zubaid M, Piegas LS, Widimsky P, Budaj A, Avezum A, Yusuf S.

Am Heart J. 2009 Apr;157(4):763-70. Epub 2009 Feb 20.PMID: 19332208 [PubMed - indexed for MEDLINE]Related articles

Dysglycemia and cardiovascular risk in the general population.

Gerstein HC.

Circulation. 2009 Feb 17;119(6):773-5. Review. No abstract available. PMID: 19221229 [PubMed - indexed for MEDLINE]Related articles

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N; Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators.

Diabetes Care. 2009 May;32(5):915-20. Epub 2009 Feb 5.PMID: 19196892 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.

Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators.

Diabetes Care. 2009 Feb;32(2):221-6.PMID: 19171735 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.

Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K; ONTARGET/TRANSCEND Investigators.

Diabetes Res Clin Pract. 2009 Mar;83(3):387-93. Epub 2009 Jan 20.PMID: 19157618 [PubMed - indexed for MEDLINE]Related articles

Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.

Ratner RE, Cannon CP, Gerstein HC, Nesto RW, Serruys PW, Van Es GA, Kolatkar NS, Kravitz BG, Zalewski A, Fitzgerald PJ; APPROACH Study Group.

Am Heart J. 2008 Dec;156(6):1074-9. Epub 2008 Oct 11.PMID: 19033001 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Goyal A, Nerenberg K, Gerstein HC, Umpierrez G, Wilson PW.

Diab Vasc Dis Res. 2008 Nov;5(4):276-84. Review.PMID: 18958837 [PubMed - indexed for MEDLINE]Related articles

Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction.

Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC, Holloway AC.

PLoS One. 2008;3(10):e3371. Epub 2008 Oct 8.PMID: 18852877 [PubMed - indexed for MEDLINE]Related articlesFree article

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S; CHARM Program Investigators.

Arch Intern Med. 2008 Aug 11;168(15):1699-704.PMID: 18695086 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. Epub 2008 Jun 6.PMID: 18539917 [PubMed - indexed for MEDLINE]Related articlesFree article

Dysglycemia and a history of reproductive risk factors.

McDonald SD, Yusuf S, Sheridan P, Anand SS, Gerstein HC; Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Trial Investigators.

Diabetes Care. 2008 Aug;31(8):1635-8. Epub 2008 May 5.PMID: 18458144 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of epicardial fat thickness and fasting glucose.

Iacobellis G, Barbaro G, Gerstein HC.

Int J Cardiol. 2008 Aug 29;128(3):424-6. Epub 2008 Mar 28.PMID: 18375002 [PubMed - indexed for MEDLINE]Related articles

Maternal nicotine exposure increases oxidative stress in the offspring.

Bruin JE, Petre MA, Lehman MA, Raha S, Gerstein HC, Morrison KM, Holloway AC.

Free Radic Biol Med. 2008 Jun 1;44(11):1919-25. Epub 2008 Mar 4.PMID: 18343235 [PubMed - indexed for MEDLINE]Related articles

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.

Diabetes Care. 2008 May;31(5):1007-14. Epub 2008 Feb 11.PMID: 18268075 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria.

Bruin JE, Gerstein HC, Morrison KM, Holloway AC.

Toxicol Sci. 2008 Jun;103(2):362-70. Epub 2008 Jan 17.PMID: 18203686 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of exercise training on insulin resistance in patients with coronary artery disease.

Suskin NG, Heigenhauser G, Afzal R, Finegood D, Gerstein HC, McKelvie RS.

Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):803-8.PMID: 18043303 [PubMed - indexed for MEDLINE]Related articles

"I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risks.

Nair KM, Levine MA, Lohfeld LH, Gerstein HC.

Can J Clin Pharmacol. 2007 Summer;14(2):e251-9. Epub 2007 Jul 27.PMID: 18000317 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth.

Holloway AC, Petrik JJ, Bruin JE, Gerstein HC.

Diabetes Obes Metab. 2008 Sep;10(9):763-71. Epub 2007 Oct 26.PMID: 17970760 [PubMed - indexed for MEDLINE]Related articles

Diabetes and cardiovascular disease: explaining the relationship.

Punthakee Z, Werstuck GH, Gerstein HC.

Rev Cardiovasc Med. 2007 Summer;8(3):145-53. Review.PMID: 17938614 [PubMed - indexed for MEDLINE]Related articles

Transgenerational effects of fetal and neonatal exposure to nicotine.

Holloway AC, Cuu DQ, Morrison KM, Gerstein HC, Tarnopolsky MA.

Endocrine. 2007 Jun;31(3):254-9.PMID: 17906372 [PubMed - indexed for MEDLINE]Related articles

Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?

Gerstein HC, Yusuf S.

Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):798-9. Epub 2007 Sep 11. No abstract available. PMID: 17848926 [PubMed]Related articles

Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study.

Voruganti LP, Punthakee Z, Van Lieshout RJ, MacCrimmon D, Parker G, Awad AG, Gerstein HC.

Schizophr Res. 2007 Nov;96(1-3):215-22. Epub 2007 Aug 30.PMID: 17764906 [PubMed - indexed for MEDLINE]Related articles

Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review.

Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L, Hunt DL.

Clin Chem Lab Med. 2007;45(9):1180-5. Review. Erratum in: Clin Chem Lab Med. 2007;45(11):1570. PMID: 17635074 [PubMed - indexed for MEDLINE]Related articles

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Goff DC Jr, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):4i-20i. Epub 2007 Apr 12. Review.PMID: 17599424 [PubMed - indexed for MEDLINE]Related articles

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. Epub 2007 Apr 19.PMID: 17599423 [PubMed - indexed for MEDLINE]Related articles

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.

Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.PMID: 17599422 [PubMed - indexed for MEDLINE]Related articles

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L.

Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. Epub 2007 Jun 29. Review.PMID: 17601626 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia.

Becker T, Moldoveanu A, Cukierman T, Gerstein HC.

Diabetes Res Clin Pract. 2007 Dec;78(3):392-7. Epub 2007 Jun 26.PMID: 17597248 [PubMed - indexed for MEDLINE]Related articles

Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure.

Bruin JE, Kellenberger LD, Gerstein HC, Morrison KM, Holloway AC.

J Endocrinol. 2007 Jul;194(1):171-8.PMID: 17592031 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.

Houlden R, Ross S, Harris S, Yale JF, Sauriol L, Gerstein HC.

Diabetes Res Clin Pract. 2007 Nov;78(2):254-8. Epub 2007 May 9.PMID: 17490781 [PubMed - indexed for MEDLINE]Related articles

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.

Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K; ONTARGET/TRANSCEND Investigators.

Circulation. 2007 Mar 20;115(11):1371-5. Epub 2007 Mar 5.PMID: 17339550 [PubMed - indexed for MEDLINE]Related articlesFree article

Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach.

Gerstein HC.

Diabetes Care. 2007 Feb;30(2):432-4. No abstract available. PMID: 17259525 [PubMed - indexed for MEDLINE]Related articlesFree article

A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.

Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM.

Diabetes Care. 2007 Feb;30(2):389-94.PMID: 17259518 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Circulation. 2007 Jan 2;115(1):114-26. Epub 2006 Dec 27.PMID: 17192512 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Diabetes Care. 2007 Jan;30(1):162-72. Review.PMID: 17192355 [PubMed - indexed for MEDLINE]Related articlesFree article

Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.

McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S.

Am J Kidney Dis. 2006 Dec;48(6):889-96.PMID: 17162143 [PubMed - indexed for MEDLINE]Related articles

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR.

Lancet. 2006 Sep 23;368(9541):1096-105. Erratum in: Lancet. 2006 Nov 18;368(9549):1770. PMID: 16997664 [PubMed - indexed for MEDLINE]Related articles

Effect of ramipril on the incidence of diabetes.

DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR.

N Engl J Med. 2006 Oct 12;355(15):1551-62. Epub 2006 Sep 15.PMID: 16980380 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.

Zinman B, Harris SB, Gerstein HC, Young TK, Raboud JM, Neuman J, Hanley AJ.

Diabetes Obes Metab. 2006 Sep;8(5):531-7.PMID: 16918588 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study.

Gerstein HC, Yale JF, Harris SB, Issa M, Stewart JA, Dempsey E.

Diabet Med. 2006 Jul;23(7):736-42.PMID: 16842477 [PubMed - indexed for MEDLINE]Related articles

Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes.

Gerstein HC.

ACP J Club. 2006 May-Jun;144(3):63. No abstract available. PMID: 16646607 [PubMed]Related articles

Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?

Hiralal R, Koo KK, Gerstein HC.

CMAJ. 2006 Apr 11;174(8):1090-1. No abstract available. PMID: 16606956 [PubMed - indexed for MEDLINE]Related articlesFree article

Why don't pigs get diabetes? Explanations for variations in diabetes susceptibility in human populations living in a diabetogenic environment.

Gerstein HC, Waltman L.

CMAJ. 2006 Jan 3;174(1):25-6. No abstract available. PMID: 16389231 [PubMed - indexed for MEDLINE]Related articlesFree article

Lisinopril inhibited the progression of renal albumin excretion in patients with insulin-dependent diabetes mellitus.

Gerstein HC.

Evid Based Cardiovasc Med. 1998 Mar;2(1):23-4. No abstract available. PMID: 16379788 [PubMed]Related articles